ACSL3 and lung adenocarcinoma: IGF2BP3 is highly expressed in lung adenocarcinoma and desensitizes ferroptosis in a manner that depends on its binding capacity to m6A-methylated mRNAs encoding anti-ferroptotic factors, including GPX4, SLC3A2, acyl-CoA synthetase long-chain family member 3 (ACSL3), and ferritin heavy chain 1 (FTH1) [92].